21.4 C
New York
Thursday, June 4, 2026

Tag: enzymes

newssourceFORcompanyinformationcontent1marketreleases

Nutrition Business Journal Releases 2026 Supplement Business Report: U.S. Market Surges Toward $100 Billion Milestone

Nutrition Business Journal Releases 2026 Supplement Business Report, Comprehensive Industry Analysis Driving Growth in Dietary Supplements

Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea

Tokyo, Japan and Cambridge, UK, 2 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”)　 announces that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation to vamorolone for the treatment of Duchenne muscular dystrophy (DMD). The Company plans to submit a Marketing Authorization Application (MAA) for vamorolone in South Korea during 2026.

Epigenetics Market worth US$4.29 billion in 2030 with 13.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 15, 2025 /PRNewswire/ -- The global Epigenetics Market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025...

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

Propanc completes pricing of an underwritten public offering of 1,000,000 shares of its common stock at a price of $4.00 per share

EU Good Food Fruits Add a Fresh Accent to Korea’s Culinary Scene

SEOUL, South Korea, Aug. 14, 2025 (GLOBE NEWSWIRE) -- EU Good Food has officially introduced premium European kiwis and canned peaches to Korean consumers, marking an important milestone in its collaboration with the Korean market. This launch highlights the initiative’s long-term commitment to delivering high-quality, fully traceable European ingredients to Korea’s food industry and households.

Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic

Ad hoc announcement pursuant to Art. 53 LR

LungExpand Pro Gains 2025 Spotlight as Plant-Based Daily Support Formula Amid Rising Public Interest in Breathing Comfort and Respiratory Wellness

Growing interest in natural respiratory support draws attention to ingredient-first formulations like LungExpand Pro, blending plant extracts and nutrients often discussed for breathing comfort and daily lung health. 
Growing interest in natural respiratory support draws attention to ingredient-first formulations like LungExpand Pro, blending plant extracts and nutrients often discussed for breathing comfort and daily lung health.

Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye

Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone) in Türkiye for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.

FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

— Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung Damage — — BRINSUPRI 10...

2025 Report: “PurDentix Reviews and Complaints” Surge Reflects Growing Curiosity Around Oral Microbiome Supplements

Consumer Search Data Reveals Expanding Curiosity Around Oral Probiotics and Ingredient Transparency in 2025 
Consumer Search Data Reveals Expanding Curiosity Around Oral Probiotics and Ingredient Transparency in 2025

AgVault Develops Ethanol’s Next Path to Value Creation Beyond Fuel

OMAHA, Neb., Aug. 5, 2025 /PRNewswire/ -- With little to no efficiency gains remaining in the ethanol production process, AgVault has developed a next...

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release

White Biotechnology: Transforming Industrial Production with Renewable Resources

Key sectors in the white biotechnology market include biofuels, biochemicals, industrial enzymes, and biomaterials, with new fields like bioremediation emerging. Advances in synthetic biology and digital tools such as machine learning are accelerating product development and market entry, driving growth from niche to large-scale industrial applications. The market is in a growth phase, buoyed by rising demand for renewable resources but challenged by high initial investment costs. Notable players include Novozymes, DuPont, BASF, and Evonik. North America is a key region, driven by government initiatives for renewable resources. 
Key sectors in the white biotechnology market include biofuels, biochemicals, industrial enzymes, and biomaterials, with new fields like bioremediation emerging. Advances in synthetic biology and digital tools such as machine learning are accelerating product development and market entry, driving growth from niche to large-scale industrial applications. The market is in a growth phase, buoyed by rising demand for renewable resources but challenged by high initial investment costs. Notable players include Novozymes, DuPont, BASF, and Evonik. North America is a key region, driven by government initiatives for renewable resources.

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara today announced that the European Medicines Agency has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEnzymes

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers